# The Effect of Albumin Value, HALP Score, and LCR Value on Predicting Survival and Recurrence in Patients With Pancreatic Adenocarcinoma

> **NCT06553040** · — · COMPLETED · sponsor: **Ege University** · enrollment: 87 (actual)

## Conditions studied

- Pancreatic Neoplasms
- Pancreas Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06553040
- **Lead sponsor:** Ege University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-01-01
- **Primary completion:** 2021-12-01
- **Final completion:** 2023-01-01
- **Target enrollment:** 87 (ACTUAL)
- **Last updated:** 2024-08-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06553040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06553040, "The Effect of Albumin Value, HALP Score, and LCR Value on Predicting Survival and Recurrence in Patients With Pancreatic Adenocarcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06553040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*